Delivery Order SPE2DE21D7020-SPE2D625F2RNL
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $11,312.43 by the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 14, 2025, with an ultimate completion date of August 21, 2025, utilizes fixed-price pricing with economic price adjustment. The delivery order is to be performed at Boston Scientific's facility in Marlborough, MA, and no small business set-aside...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,050.68 by the Defense Health Agency's Medical Supply Chain program. The contract, issued on August 4, 2025, with an ultimate completion date of August 11, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation. The place of performance is Boston Scientific's facility in Marlborough,...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,118.95 by the Defense Health Agency's Medical Supply Chain on September 16, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 23, 2025 and carries no set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,593.05 by the Defense Health Agency's Medical Supply Chain on August 28, 2025. This fixed-price contract with economic price adjustment provisions is scheduled for completion by September 5, 2025, and will be performed at Boston Scientific's facility in Marlborough, MA. The award represents a continuation of Boston Scientific's role as a critical...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $13,027.08 by the Defense Health Agency's Medical Supply Chain on August 4, 2025. The contract, which utilizes fixed-price pricing with economic price adjustment, is scheduled for completion by August 11, 2025. The award represents a non-set-aside competitive procurement, and the place of performance is Boston Scientific's facility in Marlborough, MA. As...
- Boston Scientific Corp, a major global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $32,850 by the Defense Health Agency's Medical Supply Chain under contract 4569047952. This fixed-price delivery order with economic price adjustment terms carries an ultimate completion date of August 18, 2025, and was issued on August 11, 2025. The contract is not set-aside and represents Boston Scientific's continued role as a prime...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $1,416.45 by the Defense Health Agency's Medical Supply Chain on July 29, 2025. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 5, 2025, and will be performed at Boston Scientific's facility in Marlborough, MA. The award uses no set-aside designation, allowing Boston Scientific to compete openly...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,117.24 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment is scheduled for completion by September 16, 2025, and will be performed at the company's facility in Marlborough, MA. The contract represents a continuation of Boston Scientific's established role as a prime contractor...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $6,063.45 for medical supply chain support through the Defense Health Agency's Medical Supply Chain. The contract, awarded on July 29, 2025, with an ultimate completion date of August 5, 2025, operates under a fixed-price structure with economic price adjustment provisions. This delivery order is not set aside for any specific business category, allowing Boston Scientific to compete...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $75,560 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 10, 2025. This fixed-price contract with economic price adjustment provisions represents a non-competitive award with no small business set-aside. As the place of performance is Boston Scientific's headquarters location in...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F2RNLDelivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,093.05 by the Defense Health Agency's Medical Supply Chain division. The contract, awarded on September 5, 2025, with an ultimate completion date of September 12, 2025, employs a fixed-price with economic price adjustment pricing structure and is not designated as a set-aside contract. Performance will take place at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a continuation of Boston Scientific's substantial federal contracting relationship with the Department of Defense healthcare system. The company serves as a prime contractor across multiple Defense Health Agency medical supply initiatives, providing specialized medical devices including cardiovascular intervention tools, implantable devices, and diagnostic equipment. As a single-award Blanket Purchase Agreement holder with the Defense Health Agency for radiation treatment devices (valued at $750,000 through March 30, 2030), Boston Scientific maintains a critical role in supplying advanced medical technologies to federal healthcare agencies. The relatively modest delivery order value is consistent with the company's portfolio of task orders and purchase orders executed through established indefinite delivery vehicles with various federal health organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 9/5/25 |